SYRA HEALTH CORP.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$2M
↓-13.6% -$273Kvs FY2024 (Q4)
Gross Profit
$591K
↑+65.9% +$235Kvs FY2024 (Q4)
Operating Income
$352K
↑+105.4% +$181Kvs FY2024 (Q4)
Net Income
$348K
↑+109.6% +$182Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $2M | $2M |
| COGS | $1M | $2M |
| Gross Profit | $591K | $356K |
| R&D | $139 | $0 |
| SG&A | $237K | $178K |
| D&A | $2K | $7K |
| Other OpEx | $0 | $0 |
| Operating Income | $352K | $171K |
| Interest Exp. | $4K | $6K |
| Other Non-Op | $0 | $0 |
| Pretax Income | $348K | $166K |
| Tax | $0 | $0 |
| Net Income | $348K | $166K |
QuarterCharts · SEC EDGAR data · SYRA · Comparing FY2025 (Q4) vs FY2024 (Q4)